Urgent National Drug Shortage

Posted in Latest News on October 16, 2017.

The Department of Health was alerted that Fresenius Kabi has Xylocaine with epinephrine presentations on shortage due to increased demand for the product and manufacturing delays and Pfizer has lidocaine with epinephrine presentations on shortage due to manufacturing delays.

You can read more about these shortages at:

https://www.ashp.org/drug-shortages/current-shortages/Drug-Shortage-Detail.aspx?id=860 (for lidocaine with epinephrine)

https://www.ashp.org/drug-shortages/current-shortages/Drug-Shortage-Detail.aspx?id=937 (for bupivacaine with epinephrine



More Latest News

Important Notice Regarding Oxervate
January 24, 2020

The Board of Optometry has approved Oxervate (Cenegermin-bkbj) 0.002% for addition to Rule 64B13-18.002. Continue reading


Electronic Prescribing Requirements
January 2, 2020

Click here for the new requirements requiring prescribers to generate and transmit all prescriptions electronically Continue reading